Blood Glucose Meters-Medical Devices Pipeline Assessment, 2017
Region:Global
Product Code:GDME0321EPD
April 2017
481
About the Report
Blood Glucose Meters-Medical Devices Pipeline Assessment, 2017
Summary
GlobalData's Medical Devices sector report, "Blood Glucose Meters-Medical Devices Pipeline Assessment, 2017" provides an overview of Blood Glucose Meters currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Blood Glucose Meters pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Blood Glucose Meters under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Blood Glucose Meters and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Blood Glucose Meters under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date
Scope of the Report
Companies
Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 11
1.2 List of Figures 20
2 Introduction 21
2.1 Blood Glucose Meters Overview 21
3 Products under Development 22
3.1 Blood Glucose Meters-Pipeline Products by Stage of Development 22
3.2 Blood Glucose Meters-Pipeline Products by Segment 23
3.3 Blood Glucose Meters-Pipeline Products by Territory 24
3.4 Blood Glucose Meters-Pipeline Products by Regulatory Path 26
3.5 Blood Glucose Meters-Pipeline Products by Estimated Approval Date 27
3.6 Blood Glucose Meters-Ongoing Clinical Trials 28
4 Blood Glucose Meters-Pipeline Products under Development by Companies 29
4.1 Blood Glucose Meters Companies-Pipeline Products by Stage of Development 29
4.2 Blood Glucose Meters-Pipeline Products by Stage of Development 34
5 Blood Glucose Meters Companies and Product Overview 39
5.1 4a Medicom GmbH Company Overview 39
5.2 A. Menarini Diagnostics S.r.l. Company Overview 40
5.3 Abbott Diabetes Care, Inc. Company Overview 41
5.4 Advanced Biosensors-Ohio, Llc Company Overview 47
5.5 Advanced Medical Electronics Corporation Company Overview 48
5.6 AirMarkers Company Overview 49
5.7 Animas Corp Company Overview 50
5.8 Arkal Medical, Inc. Company Overview 52
5.9 Arkray Inc Company Overview 53
5.10 Ascensia Diabetes Care Holdings AG Company Overview 54
5.11 Azurite Technologies, Inc. Company Overview 56
5.12 Bar-Ilan University Company Overview 57
5.13 Baylor University Company Overview 58
5.14 Bio-Impedance General Ltd. Company Overview 59
5.15 Biopeak Corp Company Overview 60
5.16 Biorasis, Inc. Company Overview 61
5.17 BioTelemetry Inc Company Overview 62
5.18 BioTex Inc Company Overview 63
5.19 Biovotion AG Company Overview 64
5.20 BlueVine Graphene Industries, Inc. Company Overview 66
5.21 Brigham and Women's Hospital Company Overview 68
5.22 CALISTO MEDICAL, INC. (Inactive) Company Overview 69
5.23 Cardiff University Company Overview 70
5.24 Cell MedX Corp Company Overview 71
5.25 CGM3 Ltd Company Overview 74
5.26 City, University of London Company Overview 75
5.27 Columbia University Company Overview 76
5.28 ConvaTec Group Plc Company Overview 77
5.29 Cyber Medical Ltd. Company Overview 78
5.30 DarioHealth Corp Company Overview 79
5.31 Debiotech SA Company Overview 81
5.32 DexCom Inc Company Overview 82
5.33 DiaMonTech GmbH Company Overview 87
5.34 DIRAmed LLC. Company Overview 89
5.35 DirectSens GmbH Company Overview 91
5.36 Echo Therapeutics Inc Company Overview 92
5.37 Ecole Polytechnique Federale de Lausanne Company Overview 95
5.38 eLutions Integrated Systems, Inc. Company Overview 96
5.39 Emperra GmbH E-Health Technologies Company Overview 97
5.40 EyeSense GmbH Company Overview 98
5.41 Flowsion A/S Company Overview 102
5.42 Gili Medical Ltd Company Overview 103
5.43 Globe Medical Tech Inc Company Overview 104
5.44 GlucoLight Corporation (Inactive) Company Overview 105
5.45 GlucoMe Ltd Company Overview 106
5.46 Glucometrix AG Company Overview 109
5.47 Glucosat Company Overview 110
5.48 Glucosense Diagnostics Ltd Company Overview 111
5.49 GlucoSet AS Company Overview 113
5.50 GlucoStats System Pte Ltd. Company Overview 114
5.51 Glucovation Inc Company Overview 116
5.52 GluMetrics Inc Company Overview 117
5.53 GlySens Inc Company Overview 118
5.54 GlySure Ltd Company Overview 122
5.55 Grove Instruments Inc. (Inactive) Company Overview 125
5.56 G-Sense Ltd. Company Overview 127
5.57 Guided Therapeutics Inc Company Overview 128
5.58 i360medical Limited Company Overview 129
5.59 iGlyko, Inc. Company Overview 130
5.60 Indigo Diabetes NV Company Overview 131
5.61 InLight Solutions Inc. Company Overview 132
5.62 Institute of Biomedical Engineering (ISIB-CNR) (Inactive) Company Overview 133
5.63 Insulet Corp Company Overview 134
5.64 Integrated Medical Group of Irvine Company Overview 135
5.65 Integrity Applications Ltd Company Overview 136
5.66 IntelliDx Inc Company Overview 141
5.67 Intuity Medical Inc Company Overview 142
5.68 Invivomon Inc (Inactive) Company Overview 143
5.69 Invivosense ASA (Inactive) Company Overview 144
5.70 iSense Corporation (Inactive) Company Overview 145
5.71 iXensor Co. Ltd. Company Overview 146
5.72 KeenCAT Technologies Company Overview 147
5.73 Lein Applied Diagnostics Limited Company Overview 148
5.74 LEMM Technologies, LLC Company Overview 149
5.75 LifeScan Inc Company Overview 150
5.76 LighTouch Medical, Inc. Company Overview 151
5.77 Luminous Medical Inc Company Overview 154
5.78 Lyte Labs Company Overview 155
5.79 M Pharmaceutical Inc Company Overview 156
5.80 Massachusetts Institute of Technology Company Overview 157
5.81 MASTInc Company Overview 159
5.82 Medella Health Inc. Company Overview 160
5.83 Medical Wireless Sensing Ltd Company Overview 161
5.84 Medtronic plc Company Overview 162
5.85 Mellitor Ltd. Company Overview 172
5.86 Microchips Biotech Inc Company Overview 173
5.87 MIT Spectroscopy Lab Company Overview 174
5.88 mobiLIFE Company Overview 175
5.89 Nagasaki University Company Overview 176
5.90 Nemaura Medical Inc Company Overview 177
5.91 Newton Photonics Inc Company Overview 179
5.92 NIR Diagnostics Inc. (Inactive) Company Overview 180
5.93 Northwestern University Company Overview 181
5.94 NovioSense BV Company Overview 182
5.95 Optiscan Biomedical Corp Company Overview 183
5.96 Pelikan Technologies, Inc. (Inactive) Company Overview 188
5.97 Pepex Biomedical, Inc. Company Overview 189
5.98 Pignolo SpA Company Overview 190
5.99 Pop Test LLC Company Overview 191
5.100 POPS! Diabetes Care Inc Company Overview 192
5.101 PositiveID Corp Company Overview 194
5.102 Prediktor AS Company Overview 196
5.103 Profusa, Inc. Company Overview 199
5.104 Purdue University Company Overview 200
5.105 Q Step Technologies, Inc. Company Overview 201
5.106 Roche Diabetes Care Inc Company Overview 202
5.107 Royal Adelaide Hospital SA Company Overview 204
5.108 RSP Systems A/S Company Overview 205
5.109 San Meditech (Huzhou) Co., Ltd. Company Overview 206
5.110 Senseonics, Incorporated Company Overview 207
5.111 SensiVida Medical Technologies, Inc. (Inactive) Company Overview 210
5.112 Sensys Medical, Inc. Company Overview 211
5.113 Sentec Pte Ltd Company Overview 212
5.114 Sentek Group, Inc. Company Overview 213
5.115 Senzime AB Company Overview 214
5.116 Shield Diagnostics Company Overview 216
5.117 Singapore Biomicro Pte Ltd Company Overview 217
5.118 Socrates Health Solutions, Inc. Company Overview 218
5.119 Spire Corporation Company Overview 219
5.120 St. Louis Medical Devices, Inc Company Overview 220
5.121 TecMed, Inc. Company Overview 221
5.122 Tenax Therapeutics Inc Company Overview 222
5.123 Terumo Corp Company Overview 223
5.124 Texas A&M University Company Overview 225
5.125 Ultradian Diagnostics LLC Company Overview 226
5.126 University of Bath Company Overview 227
5.127 University of California Berkeley Company Overview 228
5.128 University of California Irvine Company Overview 230
5.129 University of California San Diego Company Overview 231
5.130 University of Central Florida Company Overview 232
5.131 University of Oxford Company Overview 233
5.132 University of South Florida Company Overview 234
5.133 University of Texas at Arlington Company Overview 235
5.134 Vytrace, Inc. Company Overview 236
5.135 Zyvex Corporation Company Overview 237
6 Blood Glucose Meters- Recent Developments 238
6.1 Mar 29, 2017: ConvaTec Group: Directorate changes 238
6.2 Mar 28, 2017: Henry Ford Veteran Doctor Kimberly A. Brown to Help Lead Transplant Institute 238
6.3 Mar 28, 2017: ConvaTec: Proposed Directorate Changes 239
6.4 Mar 27, 2017: DarioHealth Launches Insurance Coverage Option for U.S. Consumers 240
6.5 Mar 27, 2017: Integrity Applications Board Appoints John Graham CEO and Chairman, Angela Strand Vice Chairman 240
6.6 Mar 24, 2017: Medicare Announces Criteria Covering Dexcom G5 Mobile CGM for All People with Diabetes on Intensive Insulin Therapy 241
6.7 Mar 24, 2017: Henry Ford Hospital Dermatologist Named Dermatology Chair 242
6.8 Mar 22, 2017: DarioHealth Reports Fourth Quarter and Year End 2016 Results 242
6.9 Mar 21, 2017: Medtronic Prices Public Offering of 1.7% Notes Due 2019 for USD1 Billion 244
6.10 Mar 21, 2017: Medtronic Prices Public Offering of 3.35% Notes Due 2027 for USD850 Million 244
6.11 Mar 21, 2017: Medtronic Prices Public Offering of 4.625% Notes Due 2045 for USD150 Million 245
6.12 Mar 21, 2017: Tenax Therapeutics Announces Year-End 2016 Financial Results and Provides Corporate Update 246
6.13 Mar 20, 2017: EKF Diagnostics Holdings: Final results 247
6.14 Mar 14, 2017: PositiveID�s E-N-G Mobile Systems� 2017 Bookings Through February Total $1.7 Million, Up More than 200% from Prior Quarter 247
6.15 Mar 13, 2017: DexCom Appoints Richard Collins to Board of Directors 248
6.16 Mar 08, 2017: Tandem Diabetes Care Reports 2016 Financial Results 248
6.17 Mar 02, 2017: EPS Bio Technology Raises USD1.9 Million in IPO 250
6.18 Mar 02, 2017: Sanofi�s Board of Directors Proposes Appointment of Melanie Lee, PhD and Bernard Charles as New Independent Directors 251
6.19 Mar 02, 2017: DarioHealth Strengthens Board of Directors with Two Additional Appointments 251
6.20 Feb 28, 2017: DexCom Reports Fourth Quarter and Fiscal Year 2016 Financial Results 252
6.21 Feb 27, 2017: Insulet Reports Fourth Quarter and Full Year 2016 Financial Results 253
6.22 Feb 23, 2017: Henry Schein Launches Newly Designed Website For A Greater Customer Experience 254
6.23 Feb 22, 2017: Another record year for Bayer � good progress with the acquisition of Monsanto 255
6.24 Feb 22, 2017: Change in the B. Braun Management Board 259
6.25 Feb 21, 2017: Henry Schein Reports Record Fourth Quarter And Full Year 2016 Financial Results 259
6.26 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 261
6.27 Feb 21, 2017: PositiveID Announces 2016 Highlights 264
6.28 Feb 16, 2017: GlucoTrack Maker Presents Scientific Data Demonstrating Reliable Accuracy and Precision 264
6.29 Feb 16, 2017: Clinical Study Confirms Continuous Glucose Monitoring is as Safe and Effective as Blood Glucose Monitoring 265
6.30 Feb 16, 2017: Ascensia Diabetes Care Presents Key Accuracy Data For CONTOUR NEXT ONE BGMS at ATTD 2017 267
6.31 Feb 16, 2017: Ascensia Diabetes Care Presents Key Accuracy Data For CONTOUR PLUS ONE BGMS at ATTD 2017 268
6.32 Feb 15, 2017: Real-World Data From Abbott's Freestyle Libre Show Association Between Higher Frequency Of Glucose Monitoring And Improved Glucose Control For People With Diabetes 268
6.33 Feb 15, 2017: Nemaura Medical to present sugarBEAT Poster at the Advanced Technologies and Treatments for Diabetes Symposium in Paris, February 16th 2017 270
6.34 Feb 15, 2017: Roche Diabetes Care Enters into Agreement with Medtronic 271
6.35 Feb 15, 2017: GluSense Raises USD1.9 Million in Financing Round 271
6.36 Feb 15, 2017: Data Presented at ATTD 2017 Demonstrate Clinical Advantages of Tandem Diabetes Care Sensor-augmented Pump over Medtronic MiniMed SAPs 271
6.37 Feb 13, 2017: Andon Health Decreases Size of Private Placement of Shares for USD101.6 Million 272
6.38 Feb 09, 2017: Henry Schein Names Bridget A. Ross To Lead Global Medical Group 272
6.39 Feb 09, 2017: Terumo Announces Change of Executive Officers 273
6.40 Feb 08, 2017: Sanofi Delivers 2016 Sales and Business EPS Growth at CER 274
6.41 Feb 07, 2017: Henry Ford Health System Names New Chair of Neurology Department 283
6.42 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 284
6.43 Feb 06, 2017: GlucoTrack Maker Appoints New Chief Financial Officer 284
6.44 Feb 01, 2017: Roche reports good results in 2016 285
6.45 Feb 01, 2017: Sanofi Appoints Hugo Fry as General Manager UK 288
6.46 Feb 01, 2017: Edwards Lifesciences Reports Fourth Quarter Results 289
6.47 Jan 31, 2017: Ascensia Diabetes Care Enters into Agreement with Glooko 290
6.48 Jan 31, 2017: Terumo Opens a Branch in Yangon 291
6.49 Jan 30, 2017: Sanofi Appoints Kathleen Tregoning to Executive Committee and Executive Vice President, External Affairs 291
6.50 Jan 30, 2017: Henry Schein Joins Takara Belmont To Support Oral Health Of At-Risk Youth In Israel By Donating State-Of-The-Art Equipment 291
6.51 Jan 26, 2017: Henry Ford Cancer Institute Earns Distinct Level of Accreditation 292
6.52 Jan 25, 2017: Novartis Plans to Spin-Off Alcon 293
6.53 Jan 25, 2017: Ypsomed opens a new production line in Solothurn 293
6.54 Jan 24, 2017: Dexcom announces publication of key study in the Journal of the American Medical Association demonstrating the value of CGM in reducing A1C and hypoglycemia in diabetes patients on injection therapy 294
6.55 Jan 24, 2017: Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Tornadoes In The South 295
6.56 Jan 23, 2017: DarioHealth Accelerates US Device Sales and Consumable Strips Growth in Fourth Quarter 296
6.57 Jan 18, 2017: Ascensia Diabetes Care Receives Health Canada License for their CONTOUR� NEXT LINK 2.4 Wireless Blood Glucose Meter as Part of the Medtronic MiniMed 630G System with SmartGuard Technology 296
6.58 Jan 17, 2017: Dr. Carsten Brunn to Lead Bayer's Pharmaceuticals Business in the Americas Region 297
6.59 Jan 12, 2017: Centers for Medicare & Medicaid Services Classify Therapeutic Continuous Glucose Monitors as "Durable Medical Equipment" under Medicare Part B 297
6.60 Jan 12, 2017: JDRF Encouraged by Medicare Decision to Take First Step Toward Coverage of Continuous Glucose Monitors for People with Type 1 Diabetes 298
6.61 Jan 11, 2017: The launch of Dexcom Canada will reshape how Canadians living with diabetes access and use continuous glucose monitoring 299
6.62 Jan 10, 2017: DexCom Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2016 and Provides Initial 2017 Outlook 300
6.63 Jan 09, 2017: OptiScan Biomedical Receives CE Mark for OptiScanner 6000 Automated Device for Monitoring Multiple Key Analytes in ICU Patients 300
6.64 Jan 09, 2017: DarioHealth Raises USD5.1 Million in Venture Financing 302
6.65 Jan 05, 2017: Intuity Medical Raises Additional USD15 Million in Series 3 Financing 302
6.66 Jan 04, 2017: Henry Ford Health System Welcomes New President and CEO 302
7 Appendix 475
7.1 Methodology 475
7.2 About GlobalData 478
7.3 Contact Us 478
7.4 Disclaimer 478
Research Methodology
Why Buy From Us?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.